Research keywords (4):
ケモカイン受容体
, マクロファージ
, PET
, 動脈硬化
Research theme for competitive and other funds (4):
2023 - 2026 Elucidation of the pathophysiology of aortic aneurysms and development of novel therapeutic agents to inhibit their progression and promote their regression
2022 - 2025 Elucidation of the function of CXCR7 on atherosclerosis and its clinical application by PET imaging
Koh Ono, Satoshi Shizuta, Erika Yamamoto, Naritatsu Saito, Neiko Ozasa, Takao Kato, Eri Kato, Takahiro Horie, Junichi Tazaki, Hiroki Shiomi, et al. Overview of the 84th Annual Scientific Meeting of the Japanese Circulation Society - Change Practice!. Circulation journal : official journal of the Japanese Circulation Society. 2021. 85. 3. 323-329
Chemokine Receptor Targeting PET Imaging of Atherosclerosis
(16th Asian Pacific Society of Atherosclerosis and Vascular Disease Congress 2023 (APSAVD2023) 2023)
The CCR2 targeting peptide-based PET tracer, 64Cu-DOTA-ECL1i can non-invasively visualize monocytes and inflammatory macrophages in atherosclerotic plaque
(Cardiovascular And Metabolic Week 2021(CVMW2021) 2021)
The CCR2 targeting peptide-based PET tracer, 64Cu-DOTA-ECL1i can non-invasively visualize monocytes and inflammatory macrophages in atherosclerotic plaque
(The 19th International Symposium on Atherosclerosis(ISA2021) 2021)
The CCR2 targeting peptide-based PET tracer, 64Cu-DOTA-ECL1i can non-invasively visualize monocytes and inflammatory macrophages in atherosclerotic plaque
(2020)
CXCR4 on Atherosclerotic Plaque Endothelium Predicts the Magnitude of Monocyte Recruitment and is Readily Targeted by PET Tracers
(2020)